Sara Ann Byron

机构：Translational Genomics Research Institute · ORCID：0000-0003-0093-0374

发表论文 194 篇 · 总被引 3511 次 · h-index 28

代表论文

• Comprehensive tumor-immune profiling reveals mediators of paradoxical immune sensitivity in sarcomatoid renal cell carcinoma (2025 · Cancer Cell · 被引 16)
• Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma (2023 · Neoplasia · 被引 15)
• Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial (2024 · Genome Medicine · 被引 14)
• Genomic analysis across 53 canine cancer types reveals novel mutations and high clinical actionability potential (2023 · Veterinary and Comparative Oncology · 被引 13)
• Standing in the canine precision medicine knowledge gap: Improving annotation of canine cancer genomic biomarkers through systematic comparative analysis of human cancer mutations in COSMIC (2023 · Veterinary and Comparative Oncology · 被引 5)
• Abstract 4706: Evaluating the efficacy of RAS(ON) inhibitor RMC-6236 combined with chemotherapy and other targeted therapies in 3D models involving patients with KRAS-mutated pancreatic cancer (2025 · Cancer Research · 被引 2)